Table 1 Neutrophil count for suspending treatment with each anticancer agent
Anticancer agent | Neutrophil count (/μl) |
|---|---|
5-fluorouracil | <1,000 |
Bendamustine | <1,000 |
Carboplatin | <1,000 |
Cisplatin | <1,000 |
Cyclophosphamide | <1,000 |
Cytarabine | <1,000 |
Docetaxel | <1,000 |
Doxorubicin | <1,000 |
Etoposide | <1,000 |
Gemucitabine | <1,000 |
Ifosfamide | <1,000 |
Irinotecan | <1,500 |
Methotorexate | <1,000 |
Oxaliplatin | <1,500 |
Paclitaxel (tri weekly) | <2,000 |
Paclitaxel (weekly) | <1,500 |
Pirarubicin | <1,000 |
Pemetrexed | <1,500 |
Vinorelbine | <2,000 |